-
MFN SHOCKWAVES BEYOND THE US: EVIDENCE OF ACCELERATED GERMAN LAUNCHES, SELECTIVE NON-ENTRY
Aug 11, 2026, 17:16 PM -
ASSESSING REGULATORY AND HTA BODY EXPECTATIONS FOR EXTERNAL CONTROL ARM STUDIES UNDER THE EU JOINT CLINICAL ASSESSMENT PROCESS
Aug 11, 2026, 17:16 PM -
BEYOND THE HEADLINES: SURFACING UNDER-RECOGNISED HEOR & MARKET-ACCESS TRENDS THROUGH A STRUCTURED 12-MONTH ENVIRONMENTAL SCAN
Aug 11, 2026, 17:16 PM -
A DECADE AFTER THE TRIPLE DISASTER: REAL-WORLD INPATIENT DATA PROFILE FROM THE ADVANCED TREATMENT HOSPITAL IN FUKUSHIMA, JAPAN
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF LECANEMAB IN PATIENTS WITH EARLY ALZHEIMER'SDISEASE IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
ORGANIZATIONAL AND ECONOMIC IMPACT OF INTRODUCING REZAFUNGIN FOR INVASIVE CANDIDIASIS IN NON-NEUTROPENIC ADULTS: COMPARISON WITH CASPOFUNGIN
Aug 11, 2026, 17:16 PM -
EARLY ECONOMIC EVALUATION OF A NOVEL ORTHOTIC CARE PATHWAY FOR HAND OSTEOARTHRITIS. A SCENARIO AND THRESHOLD ANALYSIS FROM AN NHS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
A FRAMEWORK FOR EVALUATING THE ROBUSTNESS OF EXTERNAL CONTROL ARMS IN OVARIAN CANCER VIA GENERATIVE SYNTHETIC SIMULATION
Aug 11, 2026, 17:16 PM -
QUANTITATIVE INVESTIGATION OF BACKGROUND FACTORS OF CYBERCHONDRIA IN A YOUNG ADULT SAMPLE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS OF NON-NAïVE PATIENTS INITIATING OCRELIZUMAB VERSUS MODERATE-EFFICACY TREATMENTS FOR MULTIPLE SCLEROSIS: 2-YEAR REAL-WORLD EVIDENCE FROM THE FRENCH OLIDIA STUDY
Aug 11, 2026, 17:16 PM -
STRATEGIC LAUNCH SEQUENCING UNDER MFN - REASSESSING MARKET PRIORITIZATION BEYOND TRADITIONAL PRIORITY MARKETS
Aug 11, 2026, 17:16 PM -
NICE SEVERITY MODIFIER LEVELS AND CORRESPONDING REIMBURSEMENT PATHWAYS FOR ANTICANCER THERAPIES IN SOUTH KOREA: A DESCRIPTIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF A FIXED-DOSE INTRANASAL KETAMINE AND SUFENTANIL COMBINATION FOR PEDIATRIC ACUTE PAIN IN SWEDEN
Aug 11, 2026, 17:16 PM -
COMMUNITY-BASED VERSUS FACILITY-BASED DIRECTLY OBSERVED THERAPY FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN UGANDA: A COST-UTILITY ANALYSIS
Aug 11, 2026, 17:16 PM -
STREAMLINED HTA IN THE UK: A COMPARATIVE ANALYSIS OF NICE'S PROPORTIONATE APPROACH AND SMC'S ABBREVIATED SUBMISSION PATHWAY
Aug 11, 2026, 17:16 PM -
WHOSE OUTCOMES? PATIENT INVOLVEMENT AND PATIENT-RELEVANT ENDPOINTS IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
WEIGHT LOSS EFFECTIVENESS OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1RAS) WHEN USED WITH AND WITHOUT LIFESTYLE MODIFICATIONS: A RETROSPECTIVE REAL-WORLD STUDY
Aug 11, 2026, 17:16 PM -
ESTIMATING THE HEALTH AND ECONOMIC BURDEN OF SOCIOECONOMIC INEQUALITIES IN BREAST CANCER SCREENING: AN INDIVIDUAL-LEVEL MICROSIMULATION STUDY
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND VALIDATION OF AN AI-ENABLED PLATFORM FOR AUTOMATING SYSTEMATIC LITERATURE REVIEWS: MULTI-AGENT ACCURACY ASSESSMENT ACROSS SCREENING AND DATA EXTRACTION
Aug 11, 2026, 17:16 PM -
EXPANDED VALUE MEASURES THROUGH BEHAVIOR CHANGE: AN INTERNATIONAL DELPHI CONSENSUS ON REIMBURSEMENT OF DIGITALLY ENABLED BEHAVIORAL INTERVENTIONS
Aug 11, 2026, 17:16 PM
